Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thymidylate synthase is an essential enzyme that catalyzes the conversion of deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP), a critical step in the de novo biosynthesis pathway for pyrimidine nucleotides required for DNA replication and repair. The reaction uses 5,10-methylenetetrahydrofolate as a methyl donor and produces dihydrofolate as a byproduct. In fungi—as in other eukaryotes—this enzyme is indispensable for both nuclear and mitochondrial DNA synthesis. Because its activity is vital for cell proliferation, it represents an attractive therapeutic target; inhibition leads to nucleotide imbalance and ultimately cell death due to impaired DNA synthesis ("thymineless death"). While most research has focused on human or bacterial enzymes, fungal thymidylate synthase shares conserved catalytic mechanisms but may have unique structural features exploitable by selective antifungal agents[1][6].
*For drugs targeting this enzyme class generally:* - Inhibition of dUMP methylation to dTMP, leading to depletion of dTTP pools and inhibition of DNA synthesis[1][3] *Inhibitors may act as substrate analogs or bind the folate cofactor site.*
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal thymidylate synthase (TS).